Skip to main contentAI and Advanced
/
UNICHEMLAB · NSEBSE SENSEX74,411.21+0.10%BSE |
NIFTY 5023,281+0.27%NSE |
NIFTY BANK56,167.35-0.22%NSE |
NIFTY IT29,027.1-0.21%NSE |
NIFTY AUTO27,224.1+1.23%NSE |
NIFTY FMCG45,665.7+0.23%NSE |
NIFTY PHARMA26,440.55+1.13%NSE |
NIFTY 50022,650.7+0.53%NSE |
UN
NSE · Equity shares · Major Drugs5.20 · 1.00%
Unichem Laboratories UNICHEMLAB
NSE:INR 524.25
BSE:INR 522.65
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for UNICHEMLAB
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 519.05
Day rangeINR 497.8 — INR 530.1
52-week rangeINR 278.2 — INR 687.2
Volume65,490
Market cap3,476.61
P/E8.17
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)2,201.85
Net Income (INR Cr)252.84
Rev Growth (5 Year %)12.26
EPS Growth (5 Year %)49.04
P/E Ratio8.17
Book Value384.71
EPS10.85
Price/BV1.36Computed
Research path: Interpret Unichem Laboratories's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
UNICHEMLABUnichem Laboratories1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,737.44 | 3,569.4 | 3,274.95 |
| Accumulated Depreciation Total | -759.26 | -685.93 | -585.96 |
| Other Liabilities Total | 29.06 | 40.84 | 36.67 |
| Accrued Expenses | 22.16 | 17.9 | 22.58 |
| Long Term Debt | 39.12 | 60.81 | 38.22 |
| Common Stock Total | 14.08 | 14.08 | 14.08 |
| Other Equity Total | -0.15 | -14.73 | -7.76 |
| Other Current Assets Total | 0.58 | 0.94 | 1.29 |
| Prepaid Expenses | 23.86 | 22.12 | 21.13 |
| Total Assets | 3,737.44 | 3,569.4 | 3,274.95 |
| Current Portof LT Debt/Capital Leases | 19.59 | 33.48 | 29.87 |
| Additional Paid-In Capital | 1.33 | 1.33 | 1.33 |
| Cash | 68.8 | 26.41 | 28.02 |
| Total Equity | 2,717.44 | 2,450.59 | 2,438.3 |
| Long Term Investments | 8.61 | 8.29 | 5.93 |
| Retained Earnings(Accumulated Deficit) | 2,687.48 | 2,435.21 | 2,386.45 |
| Total Common Shares Outstanding | 7.04 | 7.04 | 7.04 |
| Property/Plant/Equipment Total-Gross | 2,063.1 | 1,995.92 | 1,903.16 |
| Tangible Book Valueper Share Common Eq | 384.71 | 345.19 | 338.1 |
| Goodwill Net | 1.55 | 1.55 | 1.55 |
| Total Liabilities | 1,020 | 1,118.81 | 836.65 |
| Total Debt | 500.15 | 459.77 | 247.52 |
| Short Term Investments | 225.32 | 89.49 | 130.19 |
| Cashand Short Term Investments | 294.12 | 116.69 | 158.21 |
| Total Receivables Net | 897.81 | 896.49 | 818.41 |
| Notes Payable/Short Term Debt | 415.44 | 340.29 | 155.27 |
| Deferred Income Tax | 39.88 | 0 | 0 |
| Accounts Receivable-Trade Net | 829.67 | 780.2 | 642.54 |
| Property/Plant/Equipment Total-Net | 1,303.84 | 1,309.99 | 1,317.2 |
| Total Current Liabilities | 885.94 | 991.97 | 737.6 |
| Total Inventory | 980.97 | 993.23 | 744.28 |
| Accounts Payable | 356.63 | 402.55 | 351.26 |
| Other Currentliabilities Total | 72.12 | 197.75 | 178.62 |
| Total Long Term Debt | 65.12 | 86 | 62.38 |
| Intangibles Net | 7.33 | 18.7 | 56.36 |
| Other Long Term Assets Total | 39.78 | 65.81 | 38.05 |
| Note Receivable-Long Term | 178.99 | 135.59 | 112.54 |
| Unrealized Gain(Loss) | 14.7 | 14.7 | 44.2 |
| Total Current Assets | 2,197.34 | 2,029.47 | 1,743.32 |
| Capital Lease Obligations | 26 | 25.19 | 24.16 |
| Cash Equivalents | Not available | 0.79 | Not available |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.28
Price to Sale Ratio1.58
Growth
Debt 5Yr CAGR %33.24
Margins
Operating Margin 12m-0.66
Operating Margin 5y Avg-2.01
Net Profit Margin 12m11.48
Net Profit Margin 5y1.46
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk56.18
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Aurobindo Pharma | INR 1,589.5 | 91,456.32 | 25.09 | — |
| Neuland Laboratories | INR 21,645 | 27,583.36 | 64.28 | — |
| Pfizer | INR 4,900 | 22,334.85 | 27.53 | — |
| Jagsonpal Pharmaceuticals | INR 236.75 | 1,560.88 | 34.27 | — |
| Themis Medicare | INR 112.65 | 1,035.27 | 632.19 | — |
Shareholding
Ownership
- Promoter
- 70.22%
- FII
- 0.90%
- MF
- 9.32%
- Other
- 19.56%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Stock market today: Nifty 50 to Q2 results today, experts recommend five stocks to buy or sell on Wednesday — October 23Market news · 23 Oct 2024, 6:25 am
Stocks market today: Experts have recommended buying Unichem Laboratories, Torrent Power, Infosys, TVS Motor, and Apollo Hospitals.
Q3 results today: Bharti Airtel, Ashok Leyland among 122 companies to announce their December quarter earnings todayMarket news · 5 Feb 2024, 9:50 am
Tata Chemicals, TVS Supply Chain Solutions, eMudhra, Fusion Micro Finance, Ideaforge Technology, Insecticides (India), Linde India, Unichem Laboratories, Varun Beverages, Vijaya Diagnostic Centre among others will also declare Q3 results today.
Q1 results today: Bandhan Bank, JSW Energy, Unichem Laboratories, others to declare Q1FY24 earnings on Friday — July 14Market news · 14 Jul 2023, 8:50 am
Companies such as Bandhan Bank, JSW Energy, Tata Steel Long Products, Unichem Laboratories and Just Dial will announce their Q1 results today.
Stocks to Watch: Wipro, HCL Tech, JSW Energy, Delta Corp, Adani GreenMarket news · 14 Jul 2023, 8:03 am
JSW Energy, Bandhan Bank, CCL Products, Coromandel Engineering, Den Networks, GTPL Hathway, Just Dial, Kesoram Ind, Sastasundar Ventures, Tata Steel Long Products, Unichem Laboratories, Vandana Knitwear, and VST Industries are scheduled to announce their June quarter earnings today
Unichem Labs reports net loss of <span class='webrupee'>₹</span>44.4 crore Q4FY23Market news · 23 May 2023, 2:57 pm
Unichem laboratories reported a net loss of ₹ 44.4 crore in the April quarter of FY23. The company had reported a net consolidated profit of ₹ 71.5 crore in the April quarter of FY22
Stocks to Watch: Coal India, BPCL, Adani Power, Glenmark Pharma, ZeeMarket news · 23 May 2023, 7:22 am
JSW Energy, Akzo Nobel India, Amara Raja Batteries, Ashok Leyland, Bajaj Electricals, Biocon, CMS Info Systems, Dishman Carbogen Amcis, Dixon Technologies (India), NMDC, TTK Healthcare, and Unichem Laboratories are among companies set to announce quarterly earnings today
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsAudited Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsAudited Results
Rusaka Markets Community
Discussion and sentiment for Unichem Laboratories
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Company facts
- Industry
- Major Drugs
- Sector
- Major Drugs
- NSE Code
- UNICHEMLAB
- BSE Code
- 506690
Questions
Stock FAQ
What is the symbol and ISIN of Unichem Laboratories?
Unichem Laboratories has the symbol UNICHEMLAB and ISIN - INE351A01035.
What is the current price of Unichem Laboratories?
Unichem Laboratories is currently trading at INR 524.25.
What are the year high and year low of Unichem Laboratories?
Unichem Laboratories has a year high of INR 687.20 and a year low of INR 278.20.
What is the market capitalization of Unichem Laboratories?
Unichem Laboratories has a market capitalization of INR 3,476.61 crore.
What is the P/E ratio of Unichem Laboratories?
Unichem Laboratories has a P/E ratio of 8.17.
What is the dividend yield of Unichem Laboratories?
Unichem Laboratories has a dividend yield of 0.00%.
How is the financial performance of Unichem Laboratories based on revenue, net income, and EPS?
Unichem Laboratories has revenue of INR 2,201.85 crore, net income of INR 252.84 crore, and EPS of INR 7.69.
What is the book value of Unichem Laboratories?
Unichem Laboratories has a book value of INR 384.71.
What is the debt-to-equity ratio of Unichem Laboratories?
Unichem Laboratories has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Unichem Laboratories?
Unichem Laboratories has a price-to-book ratio of 1.36 and a price-to-sales ratio of 1.58.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.